Cargando…
The Reversible Carnitine Palmitoyltransferase 1 Inhibitor (Teglicar) Ameliorates the Neurodegenerative Phenotype in a Drosophila Huntington’s Disease Model by Acting on the Expression of Carnitine-Related Genes
Huntington’s disease (HD) is a dramatic neurodegenerative disorder caused by the abnormal expansion of a CAG triplet in the huntingtin gene, producing an abnormal protein. As it leads to the death of neurons in the cerebral cortex, the patients primarily present with neurological symptoms, but recen...
Autores principales: | Bertapelle, Carla, Carillo, Maria Rosaria, Cacciola, Nunzio Antonio, Shidlovskii, Yulii V., Peluso, Gianfranco, Digilio, Filomena Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146098/ https://www.ncbi.nlm.nih.gov/pubmed/35630602 http://dx.doi.org/10.3390/molecules27103125 |
Ejemplares similares
-
The Carnitine Palmitoyltransferase 1A Inhibitor Teglicar Shows Promising Antitumour Activity against Canine Mammary Cancer Cells by Inducing Apoptosis
por: Cacciola, Nunzio Antonio, et al.
Publicado: (2023) -
L-Carnitine in Drosophila: A Review
por: Carillo, Maria Rosaria, et al.
Publicado: (2020) -
Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014) -
Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency
por: Schnedl, Wolfgang J., et al.
Publicado: (2020) -
Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis
por: Conti, Roberto, et al.
Publicado: (2011)